Decisions, Decisions | GenomeWeb

Decisions, Decisions

In a unanimous decision yesterday, the US Supreme Court ruled in the Association for Molecular Pathology et al. v. Myriad Genetics case that human genes are not patent-eligible, though it also said that cDNA is eligible to be patented as it is not naturally occurring. The case centered on the BRCA1 and BRCA2 breast cancer genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Biotech Court

Hidden Away

Before or After?

The First Call

GINA Goes to School

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.